ANDA 40306, held by Lannett. Methylphenidate Hydrochloride.
As of Nov 19, 2026, ANDA 40306 (Metadate ER), held by Lannett, was first approved by FDA on Oct 20, 1999, with 16 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 20, 1999 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Metadate ER10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** ยท tablet, extended release;oral | Methylphenidate Hydrochloride | Discontinued |
| Oct 2, 2025 | Supplement 22Labeling ยท Standard review | Approved | None posted |
| Jun 25, 2021 | Supplement 20Labeling ยท Standard review | Approved | None posted |
| Jun 9, 2021 | Supplement 19Labeling ยท Standard review | Approved | None posted |
| Jun 9, 2021 | Supplement 18Labeling ยท Standard review | Approved | None posted |
| Jan 21, 2016 | Supplement 17Labeling ยท Standard review | Approved | None posted |
| Jan 21, 2016 | Supplement 16Labeling | Approved | None posted |
| Jan 21, 2016 | Supplement 15Labeling | Approved | None posted |
| Jan 21, 2016 | Supplement 14Labeling | Approved | None posted |
| Jan 21, 2016 | Supplement 13Labeling | Approved | None posted |
| Jan 21, 2016 | Supplement 11Labeling | Approved | None posted |
| Jan 21, 2016 | Supplement 10Labeling | Approved | None posted |
| Jan 21, 2016 | Supplement 9Labeling | Approved | None posted |
| Dec 28, 2005 | Supplement 8Labeling | Approved | None posted |
| Dec 9, 2002 | Supplement 3Manufacturing | Approved | None posted |
| Oct 9, 2002 | Supplement 2Labeling | Approved | None posted |
| May 1, 2000 | Supplement 1Manufacturing | Approved | None posted |
| Oct 20, 1999 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. โWhat FDA's review saysโ is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters